Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Chemistry sometimes reminds me of digging through attic trunks loaded with stories. Polyacrylic acid didn't land straight on pharmacy shelves. In the early 20th century, polymer science gained traction as researchers sought better materials for war and peace. Polyacrylic acid’s creation grew from the curiosity about acrylic compounds and the drive to improve water solubility and stability in manufacturing. By the 1950s, chemists took acrylic acid and used free radical polymerization, producing clear, stable, high-molecular-weight resins. Pharmaceutical grades soon followed, as demand rose for stronger, safer excipients in medicine and biotech. Today’s product is the result of layers of research, reflection, and plenty of practical need.
Polyacrylic acid, when it earns BP, EP, or USP status, steps into the pharma world with rigorous documentation behind it. Pharmacopeial grades mean every batch is certified for use in human health, not just industrial detergent or absorbent material. The resin usually comes as a white, fluffy, or granular powder. Pouring it between your fingers, you’ll notice the difference compared to industrial-type acrylics just by the lack of odor and dusty harshness.
Here’s the part where reality meets numbers. Polyacrylic acid—C3H4O2—acts like a champion when diluted in water. It swells up, forming viscous or gel-like solutions depending on molecular weight. In its standard sodium or potassium salt forms, it goes from dry powder to a sticky, clear substance quickly. The pH drops low in fully acid form, but as you neutralize it with sodium hydroxide or other bases, it forms stable gels. The melting point sits above 200°C, but decomposition, not liquidity, is what you’ll see if the temperature keeps rising. Insoluble in most organic solvents, but a friend to water, polyacrylic acid’s ion exchange properties turn useful in both formulations and removal of heavy metal ions in lab setups.
Good manufacturing practice isn't just a buzzword. On a drum or bag marked BP, EP, or USP, you’ll usually find: molecular weight range (sometimes as average), assay (purity), residual monomer (ppm), heavy metals (ppb), appearance (white to off-white), moisture level, and microbial limits. The labeling lists approved uses, batch and lot number, manufacturer details, and safety symbols. You can count on most pharma producers to provide certificates of analysis and keep batch samples for a year or more in case questions come up.
This polymer grows through free radical polymerization of acrylic acid. In a nutshell: acrylic acid combined with initiators (like persulfates or azo compounds) under nitrogen yields high molecular weight chains. The process itself can determine the quality—slow reactions often produce more uniform polymers and help remove residual monomer. For pharma grade, every step involves purification. After reaction, precipitating the polymer in alcohol removes impurities, followed by repeated washing and drying. The salt forms, such as sodium polyacrylate, result from neutralizing the acid polymer with sodium hydroxide under strict pH control. From small-batch lab scale to thousand-kilo production vessels, consistency rides on temperature, time, and reactant ratios.
Through experience in the lab, even a simple acid group can open up a world of chemistry. Polyacrylic acid’s backbone lets it undergo copolymerization with other monomers, changing water retention, stickiness, or compatibility with actives. Crosslinking stands out—add a polyol or a crosslinker like divinyl glycol, and the result is a hydrogel or bead. These derivatives do more than thicken solutions; they trap drugs, support slow release, or capture ions in medical cleaning products. Complexing with calcium, aluminum, or magnesium cations forms precursors for specialty pharmaceutical excipients, sometimes tailored for delayed tablet disintegration. Conjugating biological groups to polyacrylic chains helps create new delivery forms for vaccines or targeted therapy.
Names across labs and factories may differ but they point to similar bases: carbomer, polyacrylate, acrylic acid polymer, sodium polyacrylate, and acrylic resin. Many pharmaceutical brands keep proprietary product names, but generic substances head to market as Carbopol, Acritamer, or just plain sodium polyacrylate BP/EP/USP. The BP, EP, or USP suffix signals patient safety and regularity, clearing the product for international use among regulated manufacturers.
The strict rules in handling high-purity polyacrylic acid reflect both operational and end-user protection. In large-scale production and packing, workers wear masks and gloves to avoid dust inhalation and skin irritation. The powder is not classified as hazardous waste, but it draws attention for possible respiratory irritation. Facility air handling systems scrub out particulates, and storage occurs in sealed, moisture-proof containers to avoid clumping or unintended absorption of atmospheric water. Waste streams, whether during cleaning or accidental spills, enter neutralization units so acid pH never hits public drains. Safety data sheets, regularly updated, sit next to every drum, and informing workers about the polymer’s behavior in case of fire, soak, or breakdown forms another layer of operational safety. In the finished product, strict toxicology tests ensure absence of heavy metals, residual solvents, and unsafe microbes.
Few polymers cross from pharmacy to daily use with such adaptability. In tablet manufacturing, polyacrylic acid thickens, binds, and sometimes controls release. In topical gels, it delivers a smooth, stable feel without greasiness, cutting down the need for oily bases. I’ve seen it transform thin eye drops into slow-release therapies, providing longer relief for allergies or dry eyes. In oral products, it helps mask unpleasant tastes by keeping active APIs suspended. Some dental adhesives use polyacrylic acids for strong, biocompatible sticking power—an unsung hero behind millions of safe fillings and dental treatments. Veterinary products pull from the same stock tanks as human medicine. Outside pharma, similar compounds soak up water in diapers, keep concrete stable, and treat municipal wastewater; but only pharma grade passes into capsules, creams, and eye drops.
In the world of medical polymers, nothing stands still. Scientists continue testing modifications—grafting onto polyacrylic acid chains, blending with natural polymers, tuning molecular weights—to create drug vehicles that target, protect, or release precise amounts of medication. Injectable hydrogels pop up in bioengineering research, aiming to promote tissue regrowth or timed drug delivery. Work in responsive polymers—materials that change shape or properties in reaction to pH, heat, salt, or electric impulse—often starts with the basic polyacrylic acid backbone. The push for plant-based alternatives or greener manufacturing methods reflects a recognition that what we make should match our ethical ambitions, not just meet historic standards.
Polyacrylic acid has a long track record as an inert, biologically safe excipient. Repeated ingestion or dermal application at the intended concentrations doesn’t harm humans or animals. Studies, including those published in journals like Regulatory Toxicology and Pharmacology, point to a very low potential for systemic toxicity at expected exposure levels. Irritation, often from raw material impurities or particle size, stands as the biggest concern for workers, so good purification and dust control matter. Chronic exposure studies confirm that, outside of workplace missteps, health risks remain low. Still, research looks at late-arising questions—how microparticles behave in the body, whether certain salts cross the blood-brain barrier, and the fate of degradation products over years of repeated use.
Looking ahead, demand for smarter, safer, and more sustainable excipients grows. Polyacrylic acid sits in that mix, ready for reinvention. Formulators explore blending it with biodegradable polymers to make patches or pills that dissolve away after doing their work. Precision medicine fuels calls for polymers able to respond to changes in the body, prompting a new round of chemical tinkering with polyacrylic acid’s structure. In bioengineering, injectable systems that turn from liquid to gel at body temperature look promising for wound healing and slow-release pain relief. Streamlining manufacturing steps to pull in renewable raw materials or cut waste outputs reflects the lessons learned from decades of heavy chemical industry experience. Polyacrylic acid, in its pharma-grade forms, isn’t finished evolving. The next generation, shaped by both laboratory insight and public demand for cleaner, deeper science, signals a future where safe, reliable polymers do more than ever for medicine.
Polyacrylic Acid turns up again and again in the pharmaceutical world, especially in high-purity grades like BP, EP, and USP. What draws so much attention isn’t some fancy marketing push—it’s about how this polymer shows up in real-world medicine cabinets, in products most people use at some point. Polyacrylic Acid swells up when mixed with water, making it a true workhorse for thickening liquids and forming gels. That simple trait opens up all kinds of drug delivery options.
Many tablets don’t just need to dissolve—they need to do it in a controlled way. Polyacrylic Acid holds the key here. Drug producers rely on it in what’s called controlled-release or sustained-release products. These tablets aren’t about blasting a dose into the bloodstream all at once. Instead, Polyacrylic Acid forms a gel barrier as it absorbs water inside the body. Medicine seeps out slowly. With some blood pressure pills or diabetes drugs, this approach means fewer ups and downs, fewer forgotten doses. Patients keep living their lives without being glued to the pill bottle every few hours.
Look at nearly any topical gel—think acne treatments or burns—and Polyacrylic Acid is doing quiet work there too. It thickens up the formula quickly, holds water at the skin’s surface, and keeps active ingredients where they’re needed. Unlike some fillers or old-school gelling agents, Polyacrylic Acid doesn’t irritate sensitive skin. Ask any dermatologist about patient comfort, and you’ll hear about the role of bioinert, high-purity thickening polymers again and again.
Suspensions can be tough—the medicine in the bottle should stay evenly spread, not sink to the bottom or clump. Polyacrylic Acid keeps medicine particles floating right where they should be. For kids’ antibiotics or antacids that need to taste good and work right, that difference matters every single day. A well-made suspension isn’t just about convenience. It’s about safety: if a medicine isn’t mixed well, the person taking it could get too much or too little.
None of this matters if the raw polymer brings in contamination or impurities. BP, EP, and USP grades guarantee the level of cleanliness and quality the pharmaceutical industry demands. I’ve seen how careful manufacturers have to stay, checking every step to ensure their excipients meet international health standards. The entire supply chain—from the plant making the polymer to the pharmacist handing over the box—relies on that invisible foundation of trust. The “Pharma Grade” stamp isn’t a marketing term; it’s a condition for safety and consistency in life-saving medicines.
Some critics worry about plastics in the supply chain, and those concerns deserve respect. Polyacrylic Acid does raise questions about long-term safety, especially in the environment. There’s already a push from within the pharmaceutical sector to look for even more biodegradable, renewable polymers and to investigate better waste management. Yet, as it stands, Polyacrylic Acid remains one of the safest, most reliable tools for delivering medicine to people who need it—quickly, safely, and in the right way.
Polyacrylic acid turned up in my working life during a stint in water treatment, though these days people run into it in all sorts of industries, from detergents to pharmaceuticals. Purity is the first question that comes up anytime buyers, auditors, or quality control folks get into the details of supply. Industrial users often care most about how clean the polymer is, and it’s not just for show — residual monomers like acrylic acid, or leftover catalysts and solvents, really do matter. Unwanted ingredients can mess up formulations, drive up toxicity, or even break regulations.
Looking at a typical pharma or food additive grade, companies usually shoot for a monomer residual content under 50 parts per million (ppm) — in some more restrictive markets, under 10 ppm. As for metals, iron comes in below 5ppm, sodium and potassium rarely push past 100ppm, and heavy metals get pushed out through ion exchange or ultrafiltration. Testing with HPLC or gas chromatography gives solid answers, not just ballpark estimates.
I remember one audit where local regulations came down hard. FDA requirements set clear rules for ingredients touching food and drugs: high molecular weight polymers like polyacrylic acid are only accepted if they pass purity specifications, including low levels of monomer, heavy metals, and solvents. The European Pharmacopoeia outlines similar restrictions, focusing not just on what’s present but also process quality. REACH in Europe makes sure manufacturers take responsibility for registration, evaluation, and limitation of possible toxic constituents. Skipping compliance brings steep recalls or even a forced shutdown, which nobody in chemical manufacturing likes seeing on their record.
Certificates of Analysis do much of the heavy lifting, but buyers don’t just take someone’s word for it. Reputable buyers demand a transparent production trail, verified by both internal testing and third-party labs. Pharmacopeial grades also call for documentation around Good Manufacturing Practice (GMP), batch traceability, and impurity testing. End-users running clinical trials, for instance, are keen to avoid unknown components that could throw off their data.
In one plant I’ve visited, even minor process tweaks or new raw material sources push the QA folks to run repeated purity checks. It’s routine: titrations for carboxylic group content, pH checks, and molecular weight checks by SEC (size-exclusion chromatography). Water solubility and color from UV-Vis absorption rounds out the main set. I’ve seen some engineers grumble, but tight process control and frequent testing ward off complaints from downstream users.
The best solution I’ve seen draws on both strict supplier audits and real-time monitoring. Automation reduces the chance for operator error, and partnerships with trusted labs pick up the rare oversights. More companies push for digital batch tracking, so everything from raw material lot numbers to final container seals gets logged. That reduces uncertainty and helps answer difficult questions when an end-user’s regulator comes calling.
People talk about green chemistry, microplastic risks, and cleaner production, so demands for top-end purity won’t ease up anytime soon. Transparency from suppliers keeps shifting from a preference to a hard requirement. Polyacrylic acid isn’t a fringe specialty chemical these days — its producers need to prove, audit after audit, that every batch takes compliance seriously. Without that, reputation and business both land in rough shape.
Polyacrylic acid shows up often in pharma as a gelling agent, binder, or stabilizer. You’ll find it in controlled-release tablets, toothpastes, and wound-care products. The grade marked as BP EP USP signals production standards that sync with the British, European, and U.S. Pharmacopoeias. Meeting those monographs tells buyers the stuff matches what regulatory authorities expect for medical and nutritional applications, not just industrial use.
People don’t always realize how much chemistry shapes daily products. Polyacrylic acid thickens creams and keeps moisture locked in ointments for skin care or wound dressings. In toothpaste, it stabilizes the paste while offering a pleasant feel. In solid medicines, it helps control how fast active molecules release.
Manufacturers submit extensive data for approval. They run tests to check for contaminants, toxicity, and how the product behaves in contact with skin, mouths, or digestive tracts. For topical uses, formulators pay close attention to molecular weight and purity. Higher-quality grades keep residual monomer content low, limiting irritant potential.
Long-term data from clinical and preclinical research underline polyacrylic acid’s safety profile at the concentrations and molecular weights used in medicine. Regulatory agencies like the FDA and EMA have assessed it in pharmaceutical and cosmetic formulas for years. Studies show that the likelihood of problems comes down to what else is present — sometimes, impurities or additives (not the polymer) cause issues like skin irritation.
Allergy is rare with polyacrylic acid, especially when washed off, as with toothpaste or wound rinses. If swallowed occasionally as part of a tablet or gel, studies report no evidence of toxicity at medicinal doses. The body doesn’t absorb the polymer; it moves through the digestive system and leaves without breaking down or causing harm.
As someone who’s worked in labs, I know how tiny differences in purity or process can change product safety. Using pharma-grade material reduces the risk of cross-contamination with industrial chemicals, dust, or heavy metals. Approved grades must meet limits for microbiological purity and heavy metal content. Certificates of analysis confirm every batch passes inspection. Skipping these checks raises the risk of unexpected side effects.
Patients shouldn’t worry about polyacrylic acid in their prescribed medicines or approved skin-care products. Harm crops up only if someone uses unapproved raw materials or highly concentrated forms. I always tell colleagues: never substitute lower-grade polymers to save costs, especially in anything meant for open wounds or for swallowing.
Clear labeling, strong supplier vetting, and robust post-market surveillance all matter. Regulators count on manufacturers to follow good manufacturing practices, document any complaints, and investigate bad batches quickly. Patients need transparency about ingredients too, using resources like FDA’s database for those with rare allergies.
Polyacrylic acid – made and checked properly – plays an essential role in many medicines and personal-care staples. Ingredients like this make controlled drug delivery possible, allowing for longer-lasting painkillers or faster healing ointments. Vigilance along the supply chain makes the biggest difference. Building trust means rigorous quality checks, ongoing safety science, and listening closely if patients notice problems down the line.
Product quality depends on more than just what goes inside. Packaging plays a major role in keeping things fresh and making sure nothing goes to waste. Choices usually revolve around bags, pouches, bottles, or larger drums, depending on how much you’re moving or storing. Small batches for home kitchens often come in sealed plastic or foil pouches, offering convenience and simple storage. Retail shelves typically feature sturdy containers with easy-to-read labels, tamper-proof seals, and clear instructions, and that’s what most shoppers expect.
Bigger operations, like bakeries or production lines, lean into bulk packaging. Large multi-layer bags or durable drums cut down on handling and keep storage costs reasonable. For foodservice and manufacturing, these formats help streamline portioning and reduce the risk of spills or spoilage. Smart designs matter, too—resealable tops or moisture-proof linings block humidity and light, especially for items sensitive to air or sunlight.
People might look for that expiration date and move on, but shelf life reflects a careful balance between packaging, storage, and what the product actually is. A tightly sealed powdered product in a cool, dry place can last up to two years—sometimes longer. Dairy alternatives and similar mixes usually fall under this umbrella. Once you open a package, the clock starts ticking faster. Exposure to air, moisture, or heat can speed up clumping, off flavors, or spoilage. So opening only what you plan to use in the near future really does matter.
Some folks think adding extra preservatives will solve the problem, but the bottom line often comes down to how packaging protects what’s inside. That’s straight from experience in both small café kitchens and home pantries. Containers left open or stored near the stove never keep their best flavor. Sprinkling powder into a bowl where steam rises, for example, invites trouble. Even the smallest bit of moisture can cut shelf life by half or more. Watching those opens and closes helps get more out of a pack.
Trust in a product starts with clear packaging and honest labeling. A name, ingredient list, and expiration date are only the baseline. Look for safety seals, lot numbers for tracing, and straightforward storage instructions—that’s how reputable brands prove commitment. In the food sector, established guidelines from the FDA help set standards, while packaging technology keeps evolving to cut contamination risks.
For businesses, one solution involves training staff and setting up visual checks in storage rooms. Keep products in airtight containers, far from strong odors or fluctuating temperatures, and rotate stock regularly. At home, simple habits like closing packages tightly and keeping them away from the sink or stove really do make a difference.
Brands keep working on new packaging technologies to enhance shelf life, using oxygen absorbers, moisture barriers, or even biodegradable options. It’s not just about keeping food fresh—these changes align with consumer demand for less waste and more transparent sourcing. As someone who reads labels and cares about what goes into a cart, these shifts matter. Better packaging cuts trips to the store, saves money, and supports both families and businesses seeking long-term quality.
Polyacrylic acid in pharmaceutical grade—whether BP, EP, or USP—brings unique challenges for manufacturers and pharmacists. Having spent years inside production facilities, I’ve seen how a small misstep during storage or handling can lead to costly downgrades or worse, recalls. Manufacturers and distribution centers face tighter regulations each year, and following the best storage practices isn’t just about ticking off compliance boxes. Safeguarding the functional and physical consistency of polyacrylic acid starts long before it meets any batch process.
Polyacrylic acid pulls in water from the air at a remarkable rate. An opened drum left in a humid warehouse practically invites trouble. Excess moisture alters flow and viscosity—critical for tablet binding or gel formations. Clean, tightly sealed containers block out ambient humidity. In one site I managed in Mumbai, an error with loose lids brought in a rush of damp air during the monsoon season, which triggered a series of out-of-spec results. Keeping the product bone-dry underpins reliable performance.
Temperature control deserves more attention than it gets. Temperatures climbing over 30°C push the material closer to physical changes and might spark hydrolysis. If temperatures swing wildly, shelf life and quality both suffer. Real-world practice points to climate-controlled spaces. I’ve seen cost-driven shortcuts like storing material by an exterior door where sunlight hits, making mornings swelter and nights cool. Testing later picked up clumping and differentiation in particle size distribution. Stable, cool rooms, away from any heat sources, prove necessary for safeguarding pharma-grade quality.
Chemical purity sits at the center of pharmaceutical manufacturing rules. Polyacrylic acid absorbs vapors from more volatile chemicals. Basic cleaning supplies—bleach, ammonia—can taint a batch if stored nearby. Within one plant, moving a cleaning closet away from product storage cut down untraceable cross-contamination incidents. Designating a specific, isolated room or closed cabinet is not wasted effort—instead, it increases batch safety.
Polyacrylic acid dust can irritate lungs and skin. I’ve watched seasoned workers underestimate this, only to suffer rashes or sore throats. Wearing gloves, approved masks, and safety goggles isn’t just over-cautiousness. Dust controls, fume extraction, and spill kits give extra protection without slowing workflow. Training doesn’t just include ticking off hazard sheets—bringing in real materials for drills sharpens both comfort and attention to safe handling.
Recording each transfer, noting batch locations, logging exposure to air or temperature changes—these steps stop quality crusaders from scrambling during a surprise audit or an unplanned quality investigation. At many modern sites, digital logs have replaced hand-written binders, but the purpose remains—traceability ensures that if something does go wrong, the root cause surfaces quickly.
Manufacturers face pressure not just from regulators, but from the end-users relying on consistent results. Storing and handling polyacrylic acid isn’t an afterthought. It sits on the schedule as a daily, non-negotiable priority that pays off in fewer batch issues, better yields, and more reliable medicines reaching patients. Experienced teams make these habits automatic—right from the loading dock, through the warehouse, and into the production area.
| Names | |
| Preferred IUPAC name | poly(acrylic acid) |
| Other names |
Carbomer Acrylic acid polymer PAA Poly(acrylic acid) Propenoic acid polymer Carbopol |
| Pronunciation | /ˌpɒli.əˌkrɪl.ɪk ˈæs.ɪd biː piː iː piː juː ɛs piː ˈfɑː.mə ɡreɪd/ |
| Identifiers | |
| CAS Number | 9003-01-4 |
| Beilstein Reference | 1101968 |
| ChEBI | CHEBI:60115 |
| ChEMBL | CHEMBL1201475 |
| ChemSpider | 26052 |
| DrugBank | DB09240 |
| ECHA InfoCard | 03a2e8e8-9d69-4577-bc06-efb87fd4c6f5 |
| EC Number | 9003-01-4 |
| Gmelin Reference | Gmelin Reference: 83140 |
| KEGG | C13568 |
| MeSH | D000073494 |
| PubChem CID | 445473 |
| RTECS number | UF3985000 |
| UNII | UNII: X45W54BH90 |
| UN number | UN Not Regulated |
| Properties | |
| Chemical formula | (C3H4O2)n |
| Molar mass | 72.06 g/mol |
| Appearance | White to off-white powder |
| Odor | Odorless |
| Density | 1.22 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -0.53 |
| Acidity (pKa) | 4.5 |
| Basicity (pKb) | 11.5 |
| Refractive index (nD) | 1.480 – 1.510 |
| Viscosity | 300 to 800 cP |
| Dipole moment | 1.12 D |
| Thermochemistry | |
| Std enthalpy of formation (ΔfH⦵298) | -876 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -184.0 kJ/mol |
| Pharmacology | |
| ATC code | A06AD11 |
| Hazards | |
| Main hazards | Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| GHS labelling | GHS labelling of Polyacrylic Acid BP EP USP Pharma Grade: "GHS07, Warning, H315, H319, P264, P280, P305+P351+P338, P337+P313 |
| Pictograms | GHS05 |
| Signal word | Warning |
| Hazard statements | No hazard statement. |
| Precautionary statements | Precautionary statements: P264, P280, P305+P351+P338, P337+P313 |
| NFPA 704 (fire diamond) | 1-0-0 |
| Flash point | > 250°C |
| Autoignition temperature | > 400°C |
| LD50 (median dose) | LD50 (median dose): >5000 mg/kg (rat, oral) |
| NIOSH | Not listed |
| PEL (Permissible) | 10 mg/m³ |
| REL (Recommended) | 0.5 mg/kg |
| Related compounds | |
| Related compounds |
Polyacrylamide Polymethacrylic acid Polymaleic acid Sodium polyacrylate Polyvinyl alcohol |
Chengguan District, Lanzhou, Gansu, China
